Dihexa is a synthetic peptide developed at Washington State University that has gained significant attention in the biohacking community for its potential to physically rewire the brain. Unlike traditional nootropics that focus on neurotransmitter levels, this compound appears to encourage synaptogenesis, or the creation of new neural connections, by enhancing HGF/c-Met signaling. While animal studies and laboratory models have shown remarkable results in treating cognitive decline and brain injury, there is a complete lack of human clinical trial data regarding its safety or effectiveness. This absence of formal research leaves critical questions unanswered about optimal dosing and long-term risks, including a t ...